These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 24508037)
1. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs. McGettigan JP; David F; Figueiredo MD; Minke J; Mebatsion T; Schnell MJ Vaccine; 2014 Mar; 32(15):1716-9. PubMed ID: 24508037 [TBL] [Abstract][Full Text] [Related]
2. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination. Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157 [TBL] [Abstract][Full Text] [Related]
3. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells. Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines. Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013 [TBL] [Abstract][Full Text] [Related]
5. Relationship between virus-neutralizing antibody levels and the number of rabies vaccinations: a prospective study of dogs in Japan. Watanabe I; Yamada K; Aso A; Suda O; Matsumoto T; Yahiro T; Ahmed K; Nishizono A Jpn J Infect Dis; 2013; 66(1):17-21. PubMed ID: 23429079 [TBL] [Abstract][Full Text] [Related]
7. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs. Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816 [TBL] [Abstract][Full Text] [Related]
8. Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs. Zhou M; Wang L; Zhou S; Wang Z; Ruan J; Tang L; Jia Z; Cui M; Zhao L; Fu ZF Oncotarget; 2015 Nov; 6(36):38504-16. PubMed ID: 26436700 [TBL] [Abstract][Full Text] [Related]
9. Feline herpesvirus vectored-rabies vaccine in cats: A dual protection. Chen T; Zhou X; Qi Y; Mi L; Sun X; Zhang S; Liu Y; Olson V; Qiu W; Wu X; Hu R Vaccine; 2019 Apr; 37(16):2224-2231. PubMed ID: 30878247 [TBL] [Abstract][Full Text] [Related]
10. Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization. Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Abduraimov Y; Kondibayeva Z; Samoltyrova A; Amanova Z; Khairullin B; Sansyzbay A Arch Virol; 2017 Nov; 162(11):3363-3370. PubMed ID: 28766059 [TBL] [Abstract][Full Text] [Related]
11. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody. Lodmell DL; Parnell MJ; Weyhrich JT; Ewalt LC Vaccine; 2003 Sep; 21(25-26):3998-4002. PubMed ID: 12922136 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice. Park JE; Shin HJ Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418 [TBL] [Abstract][Full Text] [Related]
13. A single dose of an ALVAC vector-based RABV virus-like particle candidate vaccine induces a potent immune response in mice, cats and dogs. Meng X; Yan F; Wang W; Wang S; Cong H; Li J; Zhao Y; Wang T; Li N; Gao Y; Wang J; Feng N; Xia X Emerg Microbes Infect; 2024 Dec; 13(1):2406280. PubMed ID: 39295522 [TBL] [Abstract][Full Text] [Related]
14. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses. Plummer JR; McGettigan JP PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816 [TBL] [Abstract][Full Text] [Related]
15. Sero-prevalence of virus neutralizing antibodies for rabies in different groups of dogs following vaccination. Pimburage RMS; Gunatilake M; Wimalaratne O; Balasuriya A; Perera KADN BMC Vet Res; 2017 May; 13(1):133. PubMed ID: 28521804 [TBL] [Abstract][Full Text] [Related]
16. Differential Host Immune Responses after Infection with Wild-Type or Lab-Attenuated Rabies Viruses in Dogs. Gnanadurai CW; Yang Y; Huang Y; Li Z; Leyson CM; Cooper TL; Platt SR; Harvey SB; Hooper DC; Faber M; Fu ZF PLoS Negl Trop Dis; 2015; 9(8):e0004023. PubMed ID: 26292099 [TBL] [Abstract][Full Text] [Related]
17. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice. Liu C; Li J; Yao Q; Gao Z; Cheng Y; Zhou M; Tang Y; Sun L; Dai J; Cao G; Zhang XL; Zhang R Vet Microbiol; 2020 Mar; 242():108578. PubMed ID: 32122589 [TBL] [Abstract][Full Text] [Related]
18. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo. Norton JE; Lytle AG; Shen S; Tzvetkov EP; Dorfmeier CL; McGettigan JP PLoS One; 2014; 9(1):e87098. PubMed ID: 24489846 [TBL] [Abstract][Full Text] [Related]
19. Thermotolerance of an inactivated rabies vaccine for dogs. Lankester FJ; Wouters PAWM; Czupryna A; Palmer GH; Mzimbiri I; Cleaveland S; Francis MJ; Sutton DJ; Sonnemans DGP Vaccine; 2016 Nov; 34(46):5504-5511. PubMed ID: 27729174 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species. Martins M; Joshi LR; Rodrigues FS; Anziliero D; Frandoloso R; Kutish GF; Rock DL; Weiblen R; Flores EF; Diel DG Virology; 2017 Nov; 511():229-239. PubMed ID: 28898730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]